Gossamer Bio (GOSS) News Today $1.18 +0.09 (+8.26%) Closing price 05/20/2025 04:00 PM EasternExtended Trading$1.17 -0.01 (-0.85%) As of 08:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GOSS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Price T Rowe Associates Inc. MD Has $59,000 Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS)Price T Rowe Associates Inc. MD trimmed its position in shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 99.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 64,777 shMay 21 at 3:01 AM | marketbeat.comJacobs Levy Equity Management Inc. Cuts Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS)Jacobs Levy Equity Management Inc. trimmed its stake in shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 18.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,534,668 shares of the company's stock after selling 352,844 sharesMay 19 at 4:35 AM | marketbeat.comGossamer Bio (NASDAQ:GOSS) Stock Price Expected to Rise, The Goldman Sachs Group Analyst SaysMay 18 at 2:53 AM | americanbankingnews.comEarnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecastsMay 17, 2025 | uk.investing.comCantor Fitzgerald maintains Overweight on Gossamer Bio stockMay 17, 2025 | uk.investing.comGOSSAMER BIO Earnings Results: $GOSS Reports Quarterly EarningsMay 17, 2025 | nasdaq.comGossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comQ1 2025 Gossamer Bio Inc Earnings CallMay 16, 2025 | finance.yahoo.comGossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ...May 16, 2025 | finance.yahoo.comGossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comGossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA StudyMay 15, 2025 | businesswire.comGossamer Bio, Inc. (NASDAQ:GOSS) Shares Bought by Octagon Capital Advisors LPOctagon Capital Advisors LP increased its position in shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 99.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,350,000 shares of the company's stock after acquiring an addMay 15, 2025 | marketbeat.comAlyeska Investment Group L.P. Purchases 3,041,058 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS)Alyeska Investment Group L.P. boosted its position in Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 52.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,808,514 shares of the company's stock after acMay 8, 2025 | marketbeat.comGossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International ConferenceMay 7, 2025 | finance.yahoo.comGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 7, 2025 | businesswire.comAllostery Investments LP Invests $555,000 in Gossamer Bio, Inc. (NASDAQ:GOSS)Allostery Investments LP acquired a new stake in Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 613,028 shares of the company's stock, valued at approximately $555,000. GossameMay 4, 2025 | marketbeat.comGossamer Bio: Initiating Hold As Late‐Stage Data Nears InflectionMay 2, 2025 | seekingalpha.comGossamer Bio (GOSS) to Release Earnings on TuesdayGossamer Bio (NASDAQ:GOSS) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-gossamer-bio-inc-stock/)May 1, 2025 | marketbeat.comMarshall Wace LLP Sells 950,554 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS)Marshall Wace LLP lessened its stake in Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 27.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,534,378 shares of the company's stock after selling 950,554 shares during theApril 29, 2025 | marketbeat.comGossamer Bio, Inc. (NASDAQ:GOSS) Shares Acquired by Silverarc Capital Management LLCSilverarc Capital Management LLC boosted its position in shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 9.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,171,847 shares ofApril 24, 2025 | marketbeat.comPleasing Signs As A Number Of Insiders Buy Gossamer Bio StockApril 22, 2025 | finance.yahoo.comGossamer Bio, Inc. (NASDAQ:GOSS) Sees Large Growth in Short InterestGossamer Bio, Inc. (NASDAQ:GOSS - Get Free Report) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 7,970,000 shares, an increase of 38.9% from the March 15th total of 5,740,000 shares. Currently, 3.7% of the company's shares are short sold. Based on an average trading volume of 1,520,000 shares, the days-to-cover ratio is currently 5.2 days.April 20, 2025 | marketbeat.comIs Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?April 16, 2025 | msn.comGossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will TripleApril 11, 2025 | msn.comphaware® Launches Special Series of Podcast Episodes Spotlighting the Future of PH-ILD Treatment and InnovationApril 1, 2025 | finance.yahoo.comCantor Fitzgerald Forecasts Gossamer Bio FY2025 EarningsGossamer Bio, Inc. (NASDAQ:GOSS - Free Report) - Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of Gossamer Bio in a report released on Monday, March 24th. Cantor Fitzgerald analyst O. Brayer now anticipates that the company will post earnings per share of ($0.March 27, 2025 | marketbeat.comIs Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?March 26, 2025 | insidermonkey.comGossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to AnalystsMarch 23, 2025 | insidermonkey.com10 Hot Biotech Stocks Under $5March 23, 2025 | insidermonkey.comGOSSAMER BIO Earnings Preview: Recent $GOSS Insider Trading, Hedge Fund Activity, and MoreMarch 21, 2025 | nasdaq.comHC Wainwright Predicts Reduced Earnings for Gossamer BioGossamer Bio, Inc. (NASDAQ:GOSS - Free Report) - Stock analysts at HC Wainwright reduced their Q1 2025 EPS estimates for shares of Gossamer Bio in a research note issued on Tuesday, March 18th. HC Wainwright analyst P. Trucchio now expects that the company will earn ($0.16) per share for the quarMarch 21, 2025 | marketbeat.comBrokers Set Expectations for Gossamer Bio FY2028 EarningsGossamer Bio, Inc. (NASDAQ:GOSS - Free Report) - Stock analysts at HC Wainwright lowered their FY2028 EPS estimates for shares of Gossamer Bio in a report issued on Tuesday, March 18th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of $0.24 for thMarch 20, 2025 | marketbeat.comPlatinum Investment Management Ltd. Sells 344,613 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS)Platinum Investment Management Ltd. trimmed its position in shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 9.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,180,295 shares of the company's stock afterMarch 20, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Gossamer Bio (NASDAQ:GOSS)HC Wainwright reiterated a "buy" rating and issued a $10.00 price objective on shares of Gossamer Bio in a report on Tuesday.March 19, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Receives Outperform Rating from WedbushWedbush restated an "outperform" rating and issued a $4.00 price target on shares of Gossamer Bio in a research note on Friday.March 15, 2025 | marketbeat.comMonaco Asset Management SAM Acquires 1,520,721 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS)Monaco Asset Management SAM lifted its holdings in shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 39.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,371,641 shares of the company's stock after bMarch 15, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Issues Quarterly Earnings Results, Hits ExpectationsGossamer Bio (NASDAQ:GOSS - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.15) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.15).March 14, 2025 | marketbeat.comGossamer Bio (NASDAQ:GOSS) Issues Quarterly Earnings ResultsGossamer Bio (NASDAQ:GOSS - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.15) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.15).March 14, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Gossamer Bio (GOSS)March 14, 2025 | markets.businessinsider.comGossamer Bio shares rise on Q4 earnings beatMarch 13, 2025 | uk.investing.comGossamer Bio reports Q4 EPS (15c), consensus (17c)March 13, 2025 | markets.businessinsider.comGossamer Bio reports Q4 revenue $9.4M, consensus $7.0MMarch 13, 2025 | markets.businessinsider.comGossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business UpdateMarch 13, 2025 | finance.yahoo.com3 Promising Penny Stocks With Over $100M Market CapMarch 12, 2025 | finance.yahoo.comWith 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional ownersMarch 3, 2025 | finance.yahoo.comGossamer Bio (GOSS) Projected to Post Quarterly Earnings on TuesdayGossamer Bio (NASDAQ:GOSS) will be releasing earnings before the market opens on Tuesday, March 4.February 25, 2025 | marketbeat.comGossamer Bio regains Nasdaq compliance with bid priceFebruary 22, 2025 | investing.comGossamer Bio Is A Good Speculative Buy On Seralutinib For PAH And PH-ILDFebruary 13, 2025 | seekingalpha.comGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 7, 2025 | businesswire.comGossamer Bio showcases seralutinib studies at PVRI CongressFebruary 4, 2025 | msn.com Get Gossamer Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GOSS and its competitors with MarketBeat's FREE daily newsletter. Email Address GOSS Media Mentions By Week GOSS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOSS News Sentiment▼0.630.65▲Average Medical News Sentiment GOSS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOSS Articles This Week▼152▲GOSS Articles Average Week Get Gossamer Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GOSS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PAHC News Today ARDX News Today COLL News Today NTLA News Today RCUS News Today AVDL News Today SYRE News Today CRMD News Today CVAC News Today PHVS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOSS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gossamer Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gossamer Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GOSS Stock Free GOSS Stock Alerts